A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

Vitrectomy requires the substitution of the natural vitreous, as well as tamponading of retinal breaks. Clinically available alternatives such as gas and silicone oil have side effects such as inflammation, secondary glaucoma, cataract, and a need for head posturing. In this study, a hydrogel of cross-linked sodium hyaluronic acid (Healaflow(®)) is evaluated for use as a novel vitreous substitute.

Detaljer

Författare
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Oftalmologi
Originalspråkengelska
TidskriftGraefe's Archive for Clinical and Experimental Ophthalmology
Tidigt onlinedatum2016 jan 8
StatusPublished - 2016
PublikationskategoriForskning
Peer review utfördJa

Relaterad forskningsoutput

Henrik Barth, 2018, Lund: Lund University: Faculty of Medicine. 91 s.

Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

Visa alla (1)